{"id":"NCT00435162","sponsor":"Novartis Pharmaceuticals","briefTitle":"Dose Response of Valsartan on Sitting Systolic Blood Pressure in Children 6 Months - 5 Years of Age With High Blood Pressure","officialTitle":"A Randomized, Multicenter, Double-blind, 6 Week Study to Evaluate the Dose Response of Valsartan on Blood Pressure Reduction in Children 6 Months - 5 Years Old With Hypertension, Followed by a 2 Week Placebo Withdrawal Period.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-03","primaryCompletion":"2009-01","completion":"2009-01","firstPosted":"2007-02-14","resultsPosted":"2011-05-09","lastUpdate":"2011-05-09"},"enrollment":74,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Hypertension"],"interventions":[{"type":"DRUG","name":"Valsartan 0.25 mg/kg","otherNames":[]},{"type":"DRUG","name":"Valsartan 1.0 mg/kg","otherNames":[]},{"type":"DRUG","name":"Valsartan 4.0 mg/kg","otherNames":[]}],"arms":[{"label":"Low Dose","type":"EXPERIMENTAL"},{"label":"Medium Dose","type":"EXPERIMENTAL"},{"label":"High Dose","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to evaluate the safety and efficacy of three doses of valsartan (0.25, 1.0, and 4.0 mg/kg) on mean sitting systolic blood pressure (MSSBP) and mean sitting diastolic blood pressure (MSDBP) in 6 months - 5 year old children with hypertension (sitting systolic blood pressure \\[SSBP\\] ≥ 95th percentile ).","primaryOutcome":{"measure":"Change in Mean Sitting Systolic Blood Pressure (MSSBP) From Baseline to End of Period 1 (Week 6)","timeFrame":"baseline and week 6","effectByArm":[{"arm":"Low Dose","deltaMin":-8.3,"sd":10.44},{"arm":"Medium Dose","deltaMin":-10.3,"sd":9.83},{"arm":"High Dose","deltaMin":-14.4,"sd":10.93}],"pValues":[{"comp":"OG000 vs OG001 vs OG002","p":"0.0990"}]},"eligibility":{"minAge":"6 Months","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":8},"locations":{"siteCount":11,"countries":["United States","Belgium","Brazil","France","Hungary","India","Italy","Poland","South Africa","Sweden","Turkey (Türkiye)"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":15},"commonTop":["Abdominal pain","Upper respiratory tract infection","Diarrhoea","Vomiting","Pyrexia"]}}